JPM Conference Takeaways: Biotech and Biopharma Set for Growth in 2018

February 7, 2018

Fenwick’s Julia Forbess Talks Biotech Investment and Financing Trends

November 15, 2017

USPTO and EPO Examiners Discuss Key Considerations for Filing Effective Precision Medicine and Bioinformatics Applications in the US and Europe

October 27, 2017

Digital Health Companies May Find a Faster Path to Market Under the FDA’s Digital Health Plan

August 18, 2017

Martin Shkreli Convicted on Three of Eight Counts of Securities Fraud

August 7, 2017

A More Consistent USPTO Approach to Patent Eligibility

July 17, 2017

Biosimilars: Solicitor General Recommends Granting Certiorari in Amgen v. Sandoz

December 19, 2016

Will the Supreme Court Review Whether FDA-Mandated Bioequivalence Testing to Maintain Approval Falls Within the § 271(e)(1) Safe Harbor?

August 15, 2016

Federal Circuit: A Biosimilar Applicant Must Provide Notice of Intent to Market a Biosimilar Product, No Exceptions

July 20, 2016

Biosimilars: Supreme Court Calls for Solicitor General’s Views in Amgen v. Sandoz

June 23, 2016